CHGCF:OTCMKTS
Chugai Pharmaceutical Co Ltd
USDÂ 48,30
arrow_upward
+1,27%(+0,60) 1D
29 Mei, 16:00:00 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCF...
Open
USDÂ 50,72
High
USDÂ 50,72
Low
USDÂ 48,25
Mkt. cap
13,25Â bn
Avg. vol.
13,46Â k
Volume
1,36Â k
52-wk high
USDÂ 68,08
52-wk low
USDÂ 39,03
Beta
2,48
Shares outstanding
1,68Â mjd
No. of employees
5Â k
Open
USDÂ 50,72
High
USDÂ 50,72
Low
USDÂ 48,25
Mkt. cap
13,25Â bn
Avg. vol.
13,46Â k
Volume
1,36Â k
52-wk high
USDÂ 68,08
52-wk low
USDÂ 39,03
Beta
2,48
Shares outstanding
1,68Â mjd
No. of employees
5Â k
News stories
From sources across the web
Simply Wall Street
·
1 uur gelede
Can ADTRAN (ADTN) Leverage Quantum-Safe Networking To Strengthen Its Long-Term Competitive Moat?
The Globe and Mail
·
55 minute gelede
Datavault AI (NASDAQ: DVLT) to List RWA Token Programs on Perpetuals Exchange Platform
TipRanks
·
1 uur gelede
J.P. Morgan Nasdaq Equity Premium Income ETF Sees Strong Inflows Amid Tech-Led Gains
CNBC
·
4 uur gelede
Berkshire trails red-hot S&P 500 by biggest margin so far this year
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5,1Â k
Founded10 Mrt. 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp
AI content may include mistakes. Learn more